Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.
NCT07243002
·
clinicaltrials.gov ↗
RECRUITING
Status
3000
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Sponsor
Novartis Pharmaceuticals